Skip to content

Screener

Eligibility screening

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136)

Sponsored by Eli Lilly and CompanyStudy detailsClinicalTrials.gov

22 US sites in AZ, GA, NJ, NV +4

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.